Evidence map›Paper›PMID 40185780›Full record

ArticleScientific reports2025

Detection of Mycobacteria in Arabian camels and antimycobacterial potential of Moringa oleifera.

Sahar A Allam, Eman Mahrous, Sahar T M Tolba, Samy M Mohamed, Mohamed T Ragab, Rania I Mohamed

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Pneumo-/enteritis in dromedary camels (Frontiers in veterinary science · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sahar A AllamInfectious Disease Unit, Animal and Poultry Health Department, Animal and Poultry Production Division, Desert Research Center, 1 Mataria Museum Street, Cairo, 11753, Egypt. saharallam@drc.gov.eg.
Eman MahrousTB Unit, Bacteriology Department, Animal Health Research Institute, Agriculture Research Center, Giza, Egypt.
Sahar T M TolbaMicrobiology Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Samy M MohamedMedicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Institute, National Research Center, Al-Buhouth Street, Dokki, Giza, Egypt.
Mohamed T RagabInfectious Disease Unit, Animal and Poultry Health Department, Animal and Poultry Production Division, Desert Research Center, 1 Mataria Museum Street, Cairo, 11753, Egypt.
Rania I MohamedDepartment of Pathology, Animal Health Research Institute, Mansoura Provincial Laboratory, Agricultural Research Center, Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization gave great attention to Mycobacterium tuberculosis, especially its zoonotic impact. Dromedary camels in Arabian countries are of great importance, as well as awareness of production and health. Little was known about the occurrence of M. tuberculosis among Arabian camels. Out of 88 samples were collected from necropsied male camels aged 5-6.5 years after the slaughter process resident in Cairo abattoir. Isolation of Mycobacteria was achieved on Middle Brook 7H10 agar with special supplements, and then the suspected colonies were assessed by their specific aspects. Lungs and lymph nodes were processed for histopathology. Molecular characterization was carried out by both conventional amplification (Mycobacterium bovis mpb70, M. tuberculosis- Pan Mycobacterium 16S rRNA) tracked by sanger sequencing; and bacterial 16S rRNA V3-V4 hypervariable region was amplified then it was followed by Mi-seq Ilumina. Moringa oliefera's oil was analyzed by GC-MS. The antimycobacterial potential of M. oliefera was conducted by In vitro tetrazolium microplate assay (TEMA). In silico docking mode of action and prediction were studied. Mycobacterium was isolated from 9.4% (3/32) of the lung samples and 2.4% (1/41) of the recovered lymph node samples. The isolated strains had ideal culture characteristics of Mycobacterium. Sanger sequencing identified the M. tuberculosis variant bovis DRC-EG-CAMEL PQ036932. Mi-seq Illumina revealed abundant sequence readings belonging to ancestral Actinobacteria and Micromonosporaceae. In vitro testing showed that the Moringa oleifera methanol leaf extract had antimicrobial activity with MIC ranging from 7.8 to 32 µg/ml, and the seed oil showed inhibitory effects at 50% (v/v) (P value < 0.05). In silico docking of ferulic acid against M. tuberculosis variant bovis ribosomal protein S1 showed an affinity score of - 5.95 kcal/mol with one hydrogen bond. While squalene lipoprotein LprF exhibited a professional affinity score of - 6.11 kcal/mol with seventeen hydrophobic π-interactions. Mycobacterium tuberculosis variant bovis is measured to prevail in the Arabian camels. However, this study provided a detailed examination of Mycobacterium in camels, offering practical solutions to combat this pathogen and mitigate the effects of infection or zoonotic impacts on other animals and humans. Sanger sequencing is more recommended for Mycobacterium identification. Moringa oliefera's potential anti-mycobacterial effect through either leaves or oil might be achieved for humans and animals as a different strategy for medicinal plants' role. It might be a new insight into the struggle and the adverse effects of tuberculosis. In the upcoming research, therapeutic compounds could be separated from M. oliefera.

Indexed as

CamelusMoringa oleiferaMycobacteriumMycobacterium tuberculosisTuberculosisAnimalsLungLymph NodesMaleMolecular Docking SimulationMycobacterium bovisPlant OilsRNA, Ribosomal, 16SPlant OilsRNA, Ribosomal, 16SArabian camelGC–MSInfectious diseasesIn silicoIn vitroMi-seq IlluminaMoringa oleiferaMycobacterium tuberculosis variant bovisSanger sequencingSqualeneZoonosis

Identifiers

PMID40185780
PMCPMC11971359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.